Sowmya Arja, MD
Allergy & Immunology · San Francisco
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 3
- 1 carrier
- Office
- 1
Offices
1 location
Plans that list them
3 plans · 1 carrier
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Arja’s office at (415) 362-2614 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
| Imperial Courage Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Dynamic Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Senior Value (HMO C-SNP) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
California Medical Board record
Licence A167950 · Current
Licensed to practise in California · since 2020 · expires 2028-02-29 · University of Maryland School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
School, training and certification
What this clinician told their state board, medical school and everything before it. Only some states publish this, so nothing here means the state does not say, not that there was no training or certification.
Specialty certification
- American Board of Allergy and Immunology - Allergy and Immunology
- American Board of Internal Medicine - Internal Medicine
Drugs they prescribed that Part D paid
$26,716
Pharmacies billed $26,716 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 80) in 2024. At or below the middle of the specialty; the typical allergy/ immunology clinician is at 0%.
54 generic and 26 brand-name prescriptions · $26,716 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Breyna | 15 | $3,233 | $216 |
Year by year
| 2024 | 80 | 50 | 0% (0) | 33% | $26,716 |
| 2023 | 56 | 21 | 0% (0) | 55% | $32,891 |
| 2022 | 31 | 13 | 0% (0) | 48% | $348,325 |
| 2021 | 52 | 17 | 0% (0) | 54% | $35,257 |
| 2020 | 125 | 26 | None | 18% | $9,082 |
| 2019 | 181 | 56 | None | None | $16,755 |
| 2018 | 150 | 40 | None | None | $12,416 |
| 2017 | 120 | 29 | None | None | $20,467 |
| 2016 | 48 | 15 | None | None | $3,190 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2021: 1 drug
| Symbicort | 11 | $3,734 | $339 |
2020: 1 drug
| Timolol Maleate | 12 | $89 | $7 |
2019: 2 drugs
| Fluticasone Propionate | 12 | $120 | $10 |
| Amlodipine Besylate | 13 | $55 | $4 |
2018: 2 drugs
| Atorvastatin | 11 | $352 | $32 |
| Pantoprazole | 11 | $138 | $13 |
Money from drug and device companies
$233 in 2023
| 2023 | 4 | 6 | None | $233 |
| 2022 | 2 | 2 | None | $50 |
| 2021 | 1 | 1 | None | $22 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| AstraZeneca Pharmaceuticals LP | Tezspire | $148 | 2 payments
|
| GlaxoSmithKline | Nucala | $44 | 2 payments
|
| Novartis Pharmaceuticals | Xolair | $22 | 1 payment
|
| ALK-Abello | Odactra | $19 | 1 payment
|
See all 6 published payments
| GlaxoSmithKline | Meals · 2023-08-03 | Trelegy Ellipta | $21 |
| AstraZeneca Pharmaceuticals LP | Meals · 2023-05-05 | Tezspire | $23 |
| Novartis Pharmaceuticals | Meals · 2023-03-09 | Xolair | $22 |
| GlaxoSmithKline | Meals · 2023-02-24 | Nucala | $23 |
| ALK-Abello | Meals · 2023-02-10 | Odactra | $19 |
| AstraZeneca Pharmaceuticals LP | Meals · 2023-01-19 | Tezspire | $125 |
See earlier years (2022, 2021)
2022: $50
| Takeda Pharmaceuticals U.S.A. | Cuvitru | $30 | 1 payment
|
| OptiNose US | Xhance | $20 | 1 payment
|
2021: $22
| Horizon Therapeutics plc | Actimmune | $22 | 1 payment
|
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 100.0 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1215390166
- Licence
- CA A167950California A167950: Current · expires 2028-02-29
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 207RA0201X (207RA0201X)
- Mailing address
- 450 Sutter St Rm 933, San Francisco, CA, 94108
- NPI first listed
- 2016-03-29
- NPI last updated
- 2023-01-04
- NPI record certified
- 2023-01-04
This is when the NPI record was last certified, not a medical board exam.